Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin® or Any Other Oral Contraceptives (OC))

NCT00905684 COMPLETED

This study is a prospective, company-sponsored, non-interventional cohort study of up to 5000 patients in European countries and countries in Middle East who are newly prescribed any available OC. Patients will be followed up approximately 6 months after initial visit. Selection of Study Population: Women can be enrolled after decision for treatment with Yasmin or any other OC has been made. Physicians should consult the full prescribing information for the respective OC before enrolling patients and familiarize themselves with the safety information in the product package label.

Details

Lead sponsor	Bayer
Status	COMPLETED
Enrolment	5446
Start date	2009-06
Completion	2011-12

Conditions

• Contraception

Interventions

• EE30/DRSP (Yasmin, BAY86-5131)
• Any other OC

Primary outcomes

• Analyses of continuation rates and compliance stratified by the subject's knowledge on the respective topics and time spent for counseling. — After 3 months and at end of study after approx. 6 months.

Countries

Albania, Bahrain, Egypt, Hungary, Jordan, Kenya, Kuwait, Lebanon, North Macedonia, Oman, Qatar, Saudi Arabia, United Arab Emirates